Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR)

CUSIP: 517125100

Q2 2021 13F Holders as of 30 Jun 2021

Holder snapshot 6 signals
Share change
+433,560
SEC-reported price per share
$9.82
Number of holders
42
Value change
-$4,477,645
Number of buys
23
Number of sells
27
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
107,502,422

Security key

517125100

Report period

Q2 2021

Institutions

42

Top holders

10

Ownership snapshot

Top reported holders of LRMR - Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
DEERFIELD MANAGEMENT COMP...
Disclosed value leader
DEERFIELD MANAGEMENT COMP...
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F Lead comparable stake: 4.8% Showing 1-6 of 15 holder rows.

Quick read

DEERFIELD MANAGEMENT COMPANY, L.P. leads the comparable SEC ownership view at 4.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens DEERFIELD MANAGEMENT COMPANY, L.P.'s linked filing trail.
Comparable ownership Top 5
DEERFIELD MANAGEMENT COMPANY, L.P. 4.8%
RA CAPITAL MANAGEMENT, L.P. 1.4%
CHI Advisors LLC 1.4%
Vivo Capital, LLC 0.74%
ORBIMED ADVISORS LLC 0.57%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
4.8%
$75,162,000
5,144,539 shares
31 Mar 2021
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
1.4%
$22,136,000
1,515,151 shares
31 Mar 2021
CHI Advisors LLC
13F
Company
13F
1.4%
$22,136,000
1,515,148 shares
31 Mar 2021
Vivo Capital, LLC
13F
Company
13F
0.74%
$11,683,000
799,662 shares
31 Mar 2021
ORBIMED ADVISORS LLC
13F
Company
13F
0.57%
$9,018,000
617,245 shares
31 Mar 2021
VANGUARD GROUP INC
13F
Company
13F
0.44%
$6,947,000
475,536 shares
31 Mar 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
42
Shares
14,543,964
Rows available
42
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
53
Q2 2021 holders
42
Holder diff
-11
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 value Q2 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .